ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.

Feb. 27, 2026 astatine 8 a.m. ET

• President and Chief Executive Officer — Nikhil Lalwani

• Senior Vice President and Chief Financial Officer — Stephen Carey

• Senior Vice President and Head of Rare Disease — Christopher Mutz

Need a punctuation from a Motley Fool analyst? Email [email protected]

Nikhil Lalwani, President and Chief Executive Officer, Stephen Carey, Senior Vice President and Chief Financial Officer, and Christopher Mutz, Senior Vice President and Head of ANI's Rare Disease business. You tin besides entree the webcast of this telephone done the Investors conception of the ANI Pharmaceuticals, Inc. website astatine anipharmaceuticals.com. This telephone is accompanied by a descent platform that tin beryllium accessed by going to the Events of the Investors leafage of our website. You tin crook to our forward-looking statements connected Slide 2.

Before we begin, I would similar to punctual everyone that immoderate statements made connected today's league telephone that explicit a belief, expectation, projection, forecast, anticipation, oregon intent regarding aboriginal events and the company's aboriginal show whitethorn beryllium considered forward-looking statements arsenic defined by the Private Securities Litigation Reform Act. These forward-looking statements are based connected accusation disposable to ANI Pharmaceuticals, Inc. absorption arsenic of contiguous and impact risks and uncertainties, including those noted successful our property merchandise issued this greeting and our filings with the SEC. Such forward-looking statements are not guarantees of aboriginal performance. Actual results whitethorn disagree materially from those projected successful the forward-looking statements.

ANI Pharmaceuticals, Inc. specifically disclaims immoderate intent oregon work to update these forward-looking statements but arsenic required by law. During this call, we volition besides notation to definite non-GAAP fiscal measures. These non-GAAP fiscal measures should not beryllium considered arsenic an alternate to fiscal measures required by GAAP. The non-GAAP fiscal measures referenced connected this telephone are reconciled to the astir straight comparable GAAP fiscal measures successful a array disposable connected the descent platform accompanying this call. The archived webcast volition beryllium disposable for 30 days connected our website, anipharmaceuticals.com. For the payment of those who whitethorn beryllium listening to the replay oregon archived webcast, this telephone was held and reported connected February 27, 2026.

Since then, ANI Pharmaceuticals, Inc. whitethorn person made announcements related to the topics discussed, truthful delight notation the company's astir caller property releases and SEC filings. And with that, I volition crook the telephone implicit to Nikhil Lalwani.